World Pharma News / User / worldpharmanews / Voted

4
Vote

Bristol-Myers Squibb supporting efforts to help survivors

Posted by worldpharmanews 51 days ago (http://www.worldpharmanews.com)
Category: Corporate | Tags: bristol-myers squibb bms

Bristol-Myers Squibb is joining the world community in providing immediate help for survivors of the massive earthquake that struck Haiti on January 12. The company has already shipped a large donati read more »
Discuss Add this link to... Bury

4
Vote

Three new Novartis medicines approved in Japan

Posted by worldpharmanews 51 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: novartis

Patients in Japan will benefit from the approval of three new Novartis medicines - Equa® (vildagliptin), marketed as Galvus® in the European Union, for the treatment of type 2 diabetes, Exforge® (val read more »
Discuss Add this link to... Bury

2
Vote

Sanofi-aventis and employees unite for the victims of Haiti

Posted by worldpharmanews 51 days ago (http://www.worldpharmanews.com)
Category: Corporate | Tags: sanofi-aventis

In the face of the unprecedented earthquake that hit the island of Haiti, sanofi-aventis has committed 1 million Euros in financial aid to long-term reconstruction initiatives and the rehabilitation read more »
1 Comment Add this link to... Bury

3
Vote

Health 2.0 Europe - The Leading Showcase of Online and Mobile Technologies in Healthcare

Posted by worldpharmanews 57 days ago (http://www.worldpharmanews.com)
Category: Conferences & Events | Tags: health 2.0

6-7 April 2010, Paris, France.
Health 2.0 Europe, known for its live demos, will assemble speakers from 12 European countries and the U.S., in order to explain the world of Web 2.0 (both computer an read more »
Discuss Add this link to... Bury

3
Vote

Safety "Cloud" Gets Removed From Spiriva By FDA In January 2010

Posted by tjlpa 59 days ago (http://www.drug-injury.com)
Category: Blogs | Tags: spiriva fda drug-safety drug-injury

This COPD Medication Had Previously Been Possibly Linked To Stroke, Heart Attack, And Death read more »
Discuss Add this link to... Bury

2
Vote

Manhattan Research Releases New Research on DTC's Impact on Pharma Website Visitation

Posted by worldpharmanews 60 days ago (http://www.worldpharmanews.com)
Category: Research & Development | Tags: manhattan research

NuvaRing® and Latisse® are the top pharmaceutical brands in terms of having the highest percentage of overall product website traffic driven by their DTC television advertisements, according to pharm read more »
Discuss Add this link to... Bury

2
Vote

Genzyme Reports Fourth-Quarter Revenue

Posted by worldpharmanews 60 days ago (http://www.worldpharmanews.com)
Category: Financial | Tags: genzyme

Genzyme Corp. (NASDAQ: GENZ) reported that preliminary fourth-quarter revenue was $1.08 billion, compared with $1.17 billion in the same period in 2008. For the year, revenue was $4.5 billion compare read more »
Discuss Add this link to... Bury

3
Vote

FDA approves ACTEMRA for the treatment of moderately to severely active rheumatoid arthritis

Posted by worldpharmanews 60 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: roche actemra fda

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the United States (US) Food and Drug Administration (FDA) approved ACTEMRA (tocilizumab, RoACTEMRA in the European Union) for the treatment of adult read more »
Discuss Add this link to... Bury

2
Vote

Novo Nordisk starts phase 1 trial with long-acting oral GLP-1 analogue

Posted by worldpharmanews 60 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: novo nordisk nn9924

Novo Nordisk has initiated its first phase 1 clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a 2 million dollar payment to Emisphere Technologies, Inc., whose read more »
Discuss Add this link to... Bury

2
Vote

Pfizer and Strides Arcolab to Collaborate on Generic Products

Posted by worldpharmanews 60 days ago (http://www.worldpharmanews.com)
Category: Financial | Tags: pfizer strides arcolab

Pfizer (NYSE: PFE) and Strides Arcolab (BSE: 532531, NSE: STAR) announced a new collaboration, wherein Pfizer will commercialize off-patent sterile injectable and oral products in the United States t read more »
Discuss Add this link to... Bury